Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
29/04/2019 11:16 am
Bloodwork question about ipamorelin. Baseline, eight months in, and the numbers moved in a direction I did not expect.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
If you need three other compounds to notice the first one, you have not tested the first one.
Curious whether the popular dose has any basis or is just the convenient one.